Related by context. All words. (Click for frequent words.) 69 therapeutic monoclonal antibodies 68 siRNA therapeutics 68 polymerase inhibitors 68 RNA therapeutics 67 nanoviricides 66 NEUGENE 66 MEK inhibitors 66 Nanobody ® 66 Nanobodies ® 66 anticancer therapeutics 66 antiviral therapies 66 mAbs 66 prophylactic vaccine 65 recombinant antibodies 65 hemorrhagic fever viruses 65 Thiovir 65 RNAi therapeutic targeting 65 proteasome inhibitors 65 Sphingomab 65 A3 adenosine receptor 65 diagnostic biomarkers 65 predictive biomarkers 65 small molecule inhibitors 65 Therapeutic antibodies 64 small molecule defensin 64 nucleoside analogues 64 resolvins 64 peptide antigens 64 histone deacetylase HDAC 64 immunotherapeutics 64 cancer immunotherapies 64 oncolytic viruses 64 virulence factors 64 molecularly targeted 64 AMPK activators 64 Nanobody 63 JAK inhibitors 63 antisense drugs 63 TLR8 63 broadly neutralizing antibodies 63 anticancer therapies 63 Tarvacin TM 63 Tarvacin Anti Viral 63 antisense inhibitors 63 antibacterial compounds 63 GPCR targets 63 TLR antagonists 63 NovaBay Aganocide compounds 63 HDAC inhibitors 63 RNAi therapeutic 63 Aurora kinase inhibitors 63 humanized monoclonal antibodies 63 humanized antibodies 63 biologic therapeutics 63 Curaxin 63 ENMD # 62 synthetic peptides 62 HIV integrase inhibitors 62 HCV protease 62 CDK inhibitors 62 anticancer compounds 62 preclinically 62 viral proteins 62 biomarker identification 62 hormone gastrin 62 kinase inhibitors 62 SERMs 62 NEUGENE R 62 preclinical compounds 62 antisense oligonucleotides 62 oral antiviral 62 novel peptide 62 epigenetic therapies 62 prophylactic vaccines 62 THR beta agonist 62 superantigens 62 Viprovex TM 62 molecular biomarkers 62 antisense compounds 62 romazarit 62 TLR9 agonist 62 druggable targets 62 HCV polymerase inhibitors 62 aptamers 62 BCR ABL inhibitors 62 NEUGENE antisense 62 novel peptides 62 TLR9 agonists 62 immunomodulators 61 therapeutic monoclonal antibody 61 FLT3 61 Stapled Peptide 61 monoclonal antibodies 61 Nanobodies 61 monoclonal antibodies MAbs 61 sigma receptors 61 oncolytic 61 nanomedicines 61 PARP inhibitors 61 beta defensins 61 immune modulating 61 PI3K inhibitors 61 PI3K/mTOR 61 Wnt signaling pathway 61 MVA BN R 61 Anticalins 61 OncoVEX 61 monoclonal antibody MAb 61 EGFR pathway 61 ALK inhibitors 61 immunomodulatory 61 siRNA therapeutic 61 anti angiogenic drugs 61 immunotherapeutic approaches 61 filoviruses 61 immune stimulatory 61 molecularly targeted therapies 61 dAbs 61 antibody fragment 61 HCV protease inhibitors 61 novel anticancer 61 Symadex 61 paramyxoviruses 61 Neugene 61 antitumoral 61 trans splicing 61 anticancer agents 61 radezolid 61 mimetic compounds 61 viral genomes 61 monoclonal antibody therapeutics 61 Phylomer ® 61 tuberculosis bacterium 61 antiangiogenesis 61 immunotherapeutic 61 MAbs 61 ImQuest 61 viral hemorrhagic fevers 61 Listeria vaccine 61 CXCR7 61 proliferative diseases 61 integrase inhibitors 60 CXCR4 receptor 60 XmAb# 60 delafloxacin 60 oncolytic virus 60 covalent drugs 60 Lpathomab 60 AEG# 60 hematological cancers 60 antisense 60 aptamer therapeutics 60 antibody therapeutics 60 inhibit viral replication 60 CCR5 inhibitors 60 Zacharon 60 cytotoxics 60 HIV protease inhibitors 60 NS4A 60 vascular disrupting agents 60 OMP #M# 60 cathepsins 60 Novosom 60 Candida species 60 nucleoside analogs 60 virotherapy 60 BRAF inhibitors 60 proteasome inhibitor 60 JAK1 60 inhibit metastasis 60 antimicrobial compounds 60 immunological diseases 60 outer membrane proteins 60 virulence genes 60 gastro intestinal inflammation 60 antisense therapeutics 60 antifungal agents 60 HuLuc# 60 multivalent vaccine 60 Factor VIIa 60 siRNA compounds 60 anti CD# antibodies 60 CCR5 antagonists 60 Viral Immunotherapy platform 60 rifamycins 60 humanized antibody 60 thiazolides 60 viral pathogens 60 Immunotherapeutic 60 EGFR inhibitors 60 bioactive lipids 60 antisense drug 60 IAP inhibitors 60 E1A 60 drugable targets 60 immunotherapies 60 VitiGam 60 HQK 60 JAK2 inhibitor 60 CB1 antagonists 60 Galectins 60 JAK inhibitor 60 BAL# [001] 60 apoptotic pathway 60 lentiviral vectors 60 immunotoxins 60 kinase inhibition 60 Tarvacin 60 pathogenic mechanisms 60 immunogens 60 clade B 60 FGFR 60 furanones 60 intracellular pathogens 60 non nucleoside HCV 60 mucosal vaccines 60 Hedgehog pathway 60 anticoagulant reversing agent 60 JAK2 inhibitors 59 myelofibrosis polycythemia vera 59 tkRNAi 59 polyketides 59 Squalamine 59 recombinant subunit vaccine 59 tubulin binding 59 ETBs 59 enzyme inhibitors 59 NS#/#A protease 59 GSK3B 59 RIP1 kinase 59 CDDO Im 59 naturally occurring antibodies 59 nanoviricide 59 beta lactamases 59 butyrylcholinesterase 59 pox viruses 59 microRNA biomarkers 59 monoclonal antibody therapies 59 Cytolin ® 59 NNR Therapeutics 59 flaviviruses 59 CBLC# 59 novel antiviral therapeutics 59 DiLA2 59 DNA plasmids 59 small molecule activators 59 fatty acid biosynthesis 59 telomerase activators 59 Helicobacter pylori H. pylori 59 HSP# inhibitors 59 small molecule modulators 59 investigational therapies 59 biodefense pathogens 59 influenza VLP vaccine 59 protease inhibitors 59 GAP #B# 59 biodegradable nanoparticles 59 NITD# 59 CCX# 59 sirtuin therapeutics 59 PTP 1B 59 neuropsychiatric diseases 59 NNRTIs 59 immatics 59 DXL# 59 telomerase inhibitor 59 immunoregulation 59 Elvitegravir 59 influenza neuraminidase 59 dengue viruses 59 Radilex 59 intracellular signaling pathways 59 NS5b 59 histone methyltransferases HMTs 59 CMV vaccine 59 VDAs 59 glycolipids 59 HCV antiviral 59 adenoviral 59 azoles 59 p# inhibitors 59 staphylococcal infections 59 kidney urologic 59 multi kinase inhibitor 59 broadly neutralizing 59 vaccinology 59 oral prodrug 59 siRNA sequences 59 JAK3 59 tumor antigens 59 allosteric modulator 59 diagnostic biomarker 59 Nanobodies R 59 shRNA libraries 59 myeloproliferative disorders 59 live attenuated vaccines 59 oral JAK1 59 Cellzome 59 vascular disrupting agent 59 Hsp# inhibitors 59 monoclonals 59 Cempra 59 echinocandins 59 HCV protease inhibitor 59 isoform selective 59 antiviral therapeutics 59 adrenergic regulation 59 IMPDH 59 PDE# inhibitors 59 tiapamil 59 cellular pathways 59 potent inhibitors 59 PI3 kinase 59 Aurora kinase inhibitor 59 aptamer 59 Chlamydia trachomatis 59 Hedgehog inhibitor 59 cytotoxin 59 novel antibody therapeutics 59 influenza subtypes 59 recombinants 59 cardio renal 59 BRAF kinase 59 Pseudomonas aeruginosa infections 59 ImmunoVEX HSV2 59 RNA antagonists 59 EGF receptor 59 cMET 58 mAb 58 P. vivax malaria 58 enveloped viruses 58 PIK3CA 58 Epstein Barr Virus EBV 58 antimitotic 58 Aganocide ® 58 short interfering RNA 58 deacetylase inhibitors 58 immunomodulator 58 neuraminidase inhibitors 58 Cytomegalovirus CMV 58 VEGF inhibitors 58 rxRNA 58 Ramoplanin 58 cell signaling pathways 58 potently inhibit 58 antitumor 58 defensins 58 Shigamabs ® 58 HDAC inhibition 58 Onconase 58 Interferon alpha 58 proliferative disorders 58 small molecule agonists 58 fusion proteins 58 cancer immunotherapy 58 novel anti infective 58 splice variants 58 FluINsure 58 selective inhibitors 58 tubulin inhibitor 58 mucosal immunity 58 pandemic influenza viruses 58 radionuclide therapy 58 triterpenoids 58 OGeS 58 viral subtypes 58 tetravalent vaccine 58 virosome 58 SARMs 58 phage display 58 ligases 58 cytoprotective 58 nanobodies 58 poxviruses 58 Ebola Marburg 58 pathogen interactions 58 Hemopurifier TM 58 BiTE 58 DNAi 58 XmAb 58 immune modulatory 58 hedgehog pathway 58 Monoclonal antibodies 58 GlycArt 58 HIV protease 58 Epothilones 58 DAS# [001] 58 serine proteases 58 Cylene 58 CobaCyte 58 PARP inhibition 58 Vaxfectin 58 mGluR4 58 Cytolin R 58 antigen sparing 58 TLR agonists 58 BioVant 58 rxRNA TM compounds 58 sirtuin inhibitors 58 Tß4 58 Pancreate 58 tyrosine kinase inhibitors 58 nucleotide analogs 58 AdVac ® 58 therapeutic antibodies 58 ALK mutations 58 TPI ASM8 58 DepoVax 58 herpes viruses 58 cyclophilin inhibitors 58 therapeutic antibody 58 IMA# 58 Panzem 58 GPR# agonist 58 NF kB pathway 58 G Protein Coupled 58 biologic pathways 58 systemic RNAi 58 TTR gene 58 antibody 58 endogenous ligands 58 inhibit KSP 58 PEG SN# 58 nucleosides 58 chemopreventive agent 58 MMP inhibitors 58 nicotinic alpha 7 58 mda 7 58 NS4B 58 monoclonal antibody mAb 58 myeloproliferative neoplasms MPNs 58 nonviral 58 MAbs targeting 58 M. pneumoniae 58 influenza VLP vaccines 58 murine antibodies 58 Kinases 58 SIRT1 activators 58 SMT C# 58 Receptos 58 prostone 58 UsiRNAs 58 targeting PCSK9 58 molecular abnormalities 58 Kinase inhibitors 58 selective androgen receptor modulators 58 LHRH antagonists 58 bacterial strains 58 NXL# 58 HDAC 58 anti idiotype 58 viral pathogenesis 58 selective inhibition 58 respiratory viruses 58 Zolinza 58 biologic pathway 58 rxRNA compounds 58 Vaccinex 58 VRX# [002] 58 dermatophytes 58 Streptococcus pneumonia 58 tumor antigen 58 fluoroquinolone resistance 58 personalized immunotherapy 58 prolyl hydroxylase inhibitors 58 FoldRx 58 antibodies 58 poxvirus 58 replicon 58 Dicer Substrate Technology 58 vitro assay 58 OncoVEX GM CSF 58 prodrugs 58 antimicrobial peptides 57 HTS assay 57 Multimeric 57 VivaGel ™ 57 HepDirect 57 ganetespib 57 AtuRNAi 57 riboswitches 57 attenuated strain 57 arenaviruses 57 EphA2 57 Aganocide 57 bacterial fungal 57 Metallophile ™ Technology 57 peptides proteins 57 proprietary LNA 57 therapeutics 57 beta lactams 57 renin inhibitors 57 MVA BN ® 57 tyrosine kinase inhibitor 57 anti infective treatments 57 secreted proteins 57 INS# [001] 57 deCODE chemistry 57 mesenchymal cell 57 PI3K inhibitor 57 chemopreventive agents 57 JAK2 kinase 57 molecular assays 57 chemokine receptor 57 Th# 57 histone deacetylase inhibitors 57 CENP E 57 gamma secretase inhibitors 57 transfection reagents 57 avian H#N# 57 LigoCyte 57 CYC# 57 RGB # 57 EGFR HER 57 bacterial enzyme 57 HCV replication 57 effector molecules 57 opportunistic pathogens 57 S. maltophilia 57 CCR2 57 Fc receptor 57 Apo2L 57 obatoclax 57 ESBA# 57 recombinant polyclonal antibodies 57 herpesviruses 57 GMX# 57 enzyme reverse transcriptase 57 GSK3 57 Spiegelmers R 57 M2 subunit 57 antiviral 57 adaptive immunity 57 chemotherapeutics 57 HCV polymerase 57 epithelial tumors 57 Reverset 57 normal prion protein 57 lipid nanoparticle 57 Pseudomonas aeruginosa bacterium 57 multiplex assay 57 commercialize microRNA 57 Virulizin ® 57 subunit vaccine 57 Epidermal Growth Factor Receptor 57 fusion inhibitor 57 Sphingomab TM 57 LNP formulations 57 inhibit replication 57 PDE4 inhibitor 57 interferon lambda 57 PPARγ 57 protein kinase inhibitors 57 lysosomal storage diseases 57 gastrin 57 integrase inhibitor 57 NPM1 57 predictive toxicology 57 CB2 receptor 57 DNA methylation biomarkers 57 Hedgehog antagonist 57 inhibit angiogenesis 57 Adnectin 57 neuropilin 57 Azixa 57 Th# cells 57 drug conjugates ADCs 57 DsiRNA 57 bioinformatic approaches 57 IGF 1R 57 fungal organisms 57 co stimulatory molecules 57 ProLindac 57 anti infective therapeutics 57 MEK inhibitor 57 eTag assays 57 SCIB1 57 ddRNAi 57 antiproliferative effects 57 epigenetic therapeutics 57 Anticalins R 57 TLR7 57 monoclonal 57 pandemic influenza strains 57 PDE# 57 IgG1 antibody 57 selective kinase inhibitor 57 GGTase 57 miRNA therapeutics 57 nanoviricide drug 57 Antisense 57 HuCAL antibody 57 staphylococci 57 ASONEP 57 VLP vaccine 57 monoclonal antibodies mAbs 57 VLP vaccines 57 RNA viruses 57 chemokine receptors 57 oligonucleotide therapeutics 57 epothilone 57 chemically modified siRNA 57 investigational humanized monoclonal antibody 57 BRAF inhibitor 57 protein kinase inhibitor 57 carbohydrate antigens 57 nicotinic acetylcholine receptor 57 TRAIL receptor antibodies 57 HDACi 57 Aurora kinase 57 TLE3 57 pharmacogenetics 57 EGFR TKIs 57 viral antigens 57 TLR Therapeutics 57 Therapeutic Vaccine 57 thrombopoietin 57 antisense RNA 57 MT#/MEDI-# 57 tkRNAi technology 57 DGAT1 inhibitors 57 TACI Ig 57 protein misfolding diseases 57 ALN TTR 57 antigens 57 novel immunotherapies 57 bacterial toxins 57 engineered RAP peptides 57 Affibody ® molecules 57 Trofex TM 57 highly pathogenic strains 57 potent anticancer 57 IL# PE 57 selective orally bioavailable 57 AMN# [001] 57 plectasin 57 intracellular bacteria 57 TransVax TM 57 OHR/AVR# 57 immunoregulatory 57 macrolide 57 VaxImmune 57 immune modulators 57 antagomirs 57 anti secretory 57 CYT# potent vascular disrupting 57 multidrug resistance 57 dermatologic diseases 57 single stranded oligonucleotides 57 YONDELIS R 57 Nasdaq IMGN biotechnology 57 tumor subtypes 57 Radezolid 57 #beta HSD 1 57 mTOR inhibitors 57 DermaVir 57 elvucitabine 57 JAK kinases 57 signal transduction inhibitors 57 melanocortin receptors 57 Staph aureus 57 BiTE antibody 57 topical microbicide 56 underlying molecular mechanisms 56 cytolytic 56 CEQ# 56 eIF 4E 56 Fc fusion protein 56 investigational HCV polymerase 56 SIgN 56 epothilones 56 monoclonal antibody 56 microRNA therapeutics 56 otelixizumab 56 Micromet BiTE 56 maturation inhibitors 56 nanocarriers 56 anti CD3 monoclonal 56 therapeutic mAbs 56 GlgE 56 commensal bacteria 56 viral isolates 56 innate immunity 56 Gleevec resistant 56 chemical entities NCEs 56 immunomodulating 56 microRNA miRNA 56 Helicobacter 56 cyclophilin inhibitor 56 ProMune 56 respiratory viral infections 56 Smac mimetics 56 recombinant protein 56 VLPs 56 cryptococcosis 56 CRAC channel 56 serogroup B 56 cardiometabolic disorders 56 Celator 56 glycosylation profile 56 CD# antibodies 56 TB bacterium 56 Multiferon R 56 Garo H. 56 carbapenem 56 silico prediction 56 miR #a [002] 56 Interferons 56 ProNAi 56 oncogenesis 56 Aurora kinases 56 reemerging infectious diseases 56 elesclomol 56 glycan 56 Euroscreen 56 MitoQ 56 Cancer Vaccines 56 small molecule 56 Neurimmune 56 adenoviral vectors 56 brostallicin 56 antifungal compounds 56 PXD# 56 Marburg viruses 56 TRIM5a 56 JAK2 56 HGS# 56 CAMBRIDGE Mass. Alnylam Pharmaceuticals 56 biotherapeutics 56 Monoclonal antibody 56 pharmacological chaperone 56 exon skipping 56 SGLT2 inhibitors 56 posttranslational modifications 56 Cathepsin S 56 mimetics 56 antibody cytokine 56 RNA sequences 56 Guanilib 56 cancer therapeutics 56 allosteric modulation 56 Lassa virus 56 Mycobacterium tuberculosis 56 DNA gyrase 56 tRNA synthetase 56 HSP# inhibitor 56 Aviptadil 56 pharmacodynamic biomarkers 56 GPR# agonists 56 VEGF receptor 56 HCD# [002] 56 M.tb 56 hematological indications 56 REP# 56 T#I [002] 56 LentiVector technology 56 microbial pathogenesis 56 ubiquitin ligases 56 L. pneumophila 56 theranostics 56 CCR1 56 immune modulator 56 Homspera TM 56 targeting CD# 56 PARP inhibitor 56 serine protease 56 molecular determinants 56 YONDELIS 56 recombinant polyclonal antibody 56 oral proteasome inhibitor 56 reverse vaccinology 56 ChimeriVax JE 56 multidrug resistant strains 56 Apobec3 56 therapeutically relevant 56 isotype 56 Virosome Biologicals 56 nucleoside 56 siRNA reagents 56 daptomycin 56 reverse transcriptase 56 RPL# 56 cyclin dependent kinases 56 miRNA molecules 56 p# inhibitor 56 Bcr Abl mutations 56 carbon nanomaterials 56 EGFR antibodies 56 Poly ICR 56 human immunodeficiency 56 DepoVax TM 56 Respiratory Syncytial Virus RSV 56 CD# monoclonal antibody 56 transgenic rats 56 bacterial pneumonias 56 taxol 56 thalidomide Thalomid 56 OXi# 56 bioactive compounds 56 chemotherapeutic drugs 56 Curaxins 56 genomic biomarkers 56 gene rearrangements 56 aminoglycosides 56 COX enzymes 56 CDP# 56 pertuzumab 56 Dengue viruses 56 inhibits protein synthesis 56 novel VDA molecule 56 Chimigen TM 56 epitopes 56 molecular mimicry 56 Hemopurifier 56 N. gonorrhoeae 56 somatic mutations 56 stapled peptides 56 fluoroquinolone antibiotic 56 pan HDAC inhibitor 56 anticancer drugs 56 Scancell 56 lipid mediators 56 theranostic 56 human rhinovirus HRV 56 NS5A 56 Zenyaku Kogyo 56 glycosylated 56 VivaGel TM 56 renin inhibition 56 reverse transcriptase inhibitors 56 atacicept 56 Aegera 56 anticancer therapy 56 NanoViricides 56 Streptomyces bacteria 56 HCV NS3 protease 56 histone deacetylase HDAC inhibitors 56 Maxy G# 56 stem cell therapeutics 56 outlicensing 56 S/GSK# 56 neutralizing antibodies 56 E#F# 56 parainfluenza viruses 56 histone deacetylase 56 protein antigens 56 histone deacetylase inhibitor 56 AVI NEUGENE 56 multitargeted 56 ErbB3 HER3 56 anthrax toxin 56 lentiviral vector 56 LEAPS TM 56 CCR9 antagonist 56 non coding RNA 56 bacterial parasitic 56 TRV# [001] 56 Epstein Barr virus EBV 56 STK# [002] 56 BRAF mutation 56 etiological agent 56 Kleanthis G. Xanthopoulos Ph.D. 56 recombinant protein expression 56 parainfluenza virus 56 macrolides 56 Six3 56 GeoVax vaccine 56 NITD 56 activate SIRT1 56 phosphate S1P 56 Vesivirus 56 AFFiRiS 56 Galenea 56 CMV infections 56 PEGylated 56 SAR# [002] 56 epigenetic mechanisms 56 PI3K Akt 56 Gag polymorphisms 56 anti angiogenic agents 56 tubulin inhibitors 56 IgG1 56 medulloblastomas 56 CYT# 56 antitumor effects 56 mycobacterial 56 protein misfolding 56 protein homeostasis 56 Th2 cytokines 56 micro RNAs 56 Carfilzomib 56 enzyme inhibitor 56 selective immunoproteasome inhibitor 56 mtDNA mutations 55 protein tyrosine phosphatases 55 osteopontin OPN 55 parainfluenza 55 cellular immunotherapy 55 SynCon ™ DNA 55 antiviral therapy 55 IRX 2 55 Preclinical studies suggest 55 indibulin 55 myeloma cells 55 trypanosomes 55 mGlu2 3 55 Isis antisense 55 antiangiogenesis therapies 55 Protein Kinase C 55 aminolevulinic acid ALA 55 neuraminidase inhibitor 55 novel therapeutic antibodies 55 Candida infection 55 drug conjugates 55 nucleotide analogues 55 synthetic retinoid 55 Nanobody R 55 Sudhir Agrawal D.Phil 55 MIF protein 55 C5aR 55 superantigen 55 exosome 55 TLR8 agonist 55 candidate CRLX# 55 bacterial pathogens 55 FBPase 55 FTIs 55 Maribavir 55 Protease inhibitors 55 ATL# [001] 55 VIRxSYS 55 anionic backbone 55 SCYNEXIS 55 NPC 1C 55 IgG antibodies 55 Cytolin 55 Akt inhibitor 55 signaling cascades 55 interferons 55 endostatin 55 Src inhibitors 55 Dr. Vitetta 55 huC# DM4 55 Locked Nucleic Acid LNA 55 chimeric protein 55 vivo validation 55 HDL Mimetic Peptide 55 prognostic markers 55 sodium glucose transporter 55 malaria parasite Plasmodium falciparum 55 oxidative stress inducer 55 Hendra viruses 55 blood coagulation disorders 55 pneumococcal serotypes 55 microRNAs miRNAs 55 enzymatic pathway 55 immunomodulatory properties 55 virus AAV 55 biased ligand 55 DOS# 55 orally administered inhibitor 55 specific lectin receptors 55 ATL/TV# 55 T. cruzi 55 organ transplant rejection 55 carbohydrate polymers 55 herpes simplex viruses 55 PER.C6 ® 55 RNA silencing 55 delta isoform 55 capsular polysaccharide 55 Cryptococcus neoformans 55 ZFP Therapeutic 55 CXCR4 55 DCVax R 55 Valortim R 55 autism susceptibility genes 55 Cathepsin B 55 engineered proteases 55 DermaVir Patch 55 pharmacologic agents 55 Candida albicans 55 DepoVax ™ 55 dependent cellular cytotoxicity 55 direct thrombin inhibitors 55 hERG 55 flu mAb 55 mitochondrial disorders 55 Angiocept 55 GRNVAC1 55 cyclin dependent kinases CDKs 55 coronaviruses 55 antibacterial therapeutics 55 antimetastatic 55 flavopiridol 55 methyltransferases 55 CD4 receptor 55 SynCon 55 molecular pathogenesis